| Not Yet Recruiting | Disposable Endoscope Platform in Third Space Endoscopic Procedures NCT06738628 | Baylor College of Medicine | — |
| Not Yet Recruiting | Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patien NCT06783504 | Indiana University | N/A |
| Recruiting | Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms NCT04661215 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | Gastric Emptying Recovery After GLP-1 RA Cessation NCT07360262 | Wonkwang University Hospital | — |
| Recruiting | Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gas NCT07104214 | Zhejiang University | — |
| Not Yet Recruiting | G-POEM for Glycemic Control in Diabetic Gastroparesis NCT06965543 | French Society of Digestive Endoscopy | N/A |
| Recruiting | Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP) NCT06732453 | Wake Forest University Health Sciences | N/A |
| Withdrawn | Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial NCT06173336 | University of Arkansas | N/A |
| Active Not Recruiting | Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator NCT07526935 | Baylor Research Institute | N/A |
| Not Yet Recruiting | Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects NCT06854120 | University of Auckland, New Zealand | — |
| Completed | Validation of Plant-Based Vegan Meal for Gastric Emptying Testing in 10 Healthy Subjects NCT06991036 | Mayo Clinic | N/A |
| Recruiting | GpCRC Pediatric Gastroparesis Registry 2 NCT05981300 | Johns Hopkins Bloomberg School of Public Health | — |
| Recruiting | The Role of AAT After Abdominal Surgery Based on RWS NCT06580197 | Peking Union Medical College Hospital | — |
| Recruiting | The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM NCT06493032 | Indiana University | N/A |
| Recruiting | Growth Hormone for the Treatment of Gastroparesis NCT06803589 | Mayo Clinic | EARLY_Phase 1 |
| Recruiting | Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction NCT06510348 | Romanian Society for Enteral and Parenteral Nutrition | N/A |
| Recruiting | TENS in Scleroderma NCT06646913 | University of Michigan | Phase 1 |
| Recruiting | Gastroparesis Registry 4 NCT05846802 | Johns Hopkins Bloomberg School of Public Health | — |
| Recruiting | Mechanisms of Action for the Enterra Medical Gastric Electrical Stimulator NCT06582576 | University of Aarhus | — |
| Completed | Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy NCT06533527 | The Cleveland Clinic | Phase 4 |
| Recruiting | Study of Enhanced Programming Stimulation with the Enterra® Therapy System NCT06560307 | Enterra Medical, Inc. | N/A |
| Recruiting | Predicting Outcomes of GPOEM Using Gastric Electrical Mapping NCT06381349 | Chris Varghese | — |
| Completed | Effects of Liraglutide on Body Surface Gastric Mapping NCT06500130 | Alimetry | N/A |
| Recruiting | Body Surface Gastric Mapping Vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis NCT06411574 | University of Western Sydney | N/A |
| Not Yet Recruiting | Validation of a Mental Health Scale for Young People With Chronic Stomach Symptoms NCT06394154 | Greg O'Grady | — |
| Recruiting | Body Surface Gastric Mapping in Patients on Semaglutide NCT06401746 | University of Western Sydney | — |
| Completed | Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy NCT06292065 | Nils Vlaeminck | N/A |
| Recruiting | G-POEM vs PEG-J in Gastroparesis Patients NCT06372132 | Maastricht University Medical Center | N/A |
| Withdrawn | Cereset Research For Chronic Nausea NCT05229107 | Wake Forest University Health Sciences | N/A |
| Recruiting | Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis NCT06836557 | Vanda Pharmaceuticals | Phase 3 |
| Withdrawn | Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis NCT05405842 | Stanford University | N/A |
| Completed | Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking NCT06038734 | University of North Carolina, Chapel Hill | — |
| Unknown | G-POEM for Refractory Gastroparesis After Esophagectomy With Gastric Pull-through NCT06068127 | Institute for Clinical and Experimental Medicine | — |
| Unknown | Automated Insulin Delivery in Type 1 Diabetes Complicated by Gastroparesis NCT05795309 | Imperial College London | N/A |
| Completed | A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis NCT04869670 | Mayo Clinic | N/A |
| Recruiting | Study of Enterra Programming with Nocturnal Cycling in Gastroparetics NCT05980455 | Enterra Medical, Inc. | N/A |
| Unknown | Comparison of the Atmo Motility Gas Capsule System to the Reference Standard NCT05718505 | Atmo Biosciences Pty Ltd | N/A |
| Completed | Establishing a Pediatric Reference Range for the 13C-Spirulina Gastric Emptying Breath Test (GEBT) NCT06004596 | Cairn Diagnostics | N/A |
| Recruiting | ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts NCT05647135 | Romanian Society for Enteral and Parenteral Nutrition | — |
| Recruiting | Study of Gastric Motility in Eosinophilic Gastritis NCT05229432 | Children's Hospital Medical Center, Cincinnati | — |
| Recruiting | Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes NCT04696159 | Matthew Allemang | N/A |
| Completed | Different Doses of Naronapride vs. Placebo in Gastroparesis NCT05621811 | Dr. Falk Pharma GmbH | Phase 2 |
| Recruiting | Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis NCT06661668 | Evangelic Hospital Kalk Cologne | — |
| Unknown | HR-EGG in Medically Refractory Gastroparesis NCT05789511 | University of Virginia | — |
| Enrolling By Invitation | Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls NCT05812339 | University of Calgary | — |
| Unknown | EGG Test as a Predictor for an Individual Response to Treatment by Various Bariatric Procedures NCT05731531 | Asian Institute of Gastroenterology, India | N/A |
| Unknown | To Study the EGG Abnormalities in Healthy Subjects and in Patients With Idiopathic and Diabetic Gastroparesis. NCT05624034 | Asian Institute of Gastroenterology, India | — |
| Unknown | Respiratory and Hemodynamic Implications of Endoscopic Myotomy of the Esophagus and Stomach NCT05602272 | Centre Hospitalier Universitaire Vaudois | — |
| Recruiting | Gastric Pathophysiology in Diabetes NCT06068114 | Institute for Clinical and Experimental Medicine | — |
| Withdrawn | Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia NCT05055336 | University of Miami | N/A |
| Withdrawn | Intestinal Permeability and Gastroparesis NCT04894656 | Mayo Clinic | N/A |
| Completed | Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis NCT05270460 | Processa Pharmaceuticals | Phase 2 |
| Active Not Recruiting | Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial NCT05039424 | Matthew Allemang | N/A |
| Withdrawn | Gastroparesis in Cystic Fibrosis NCT05223881 | University of Miami | N/A |
| Active Not Recruiting | Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility NCT05004012 | University of California, Los Angeles | N/A |
| Recruiting | Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Dis NCT05905016 | AdventHealth | — |
| Recruiting | BSGM to Evaluate Patients With GI Symptoms NCT05880199 | Children's Hospital of Philadelphia | — |
| Suspended | A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis NCT05079568 | Mayo Clinic | N/A |
| Withdrawn | Use of EndoFLIP and Manometry Prior to G-POEM NCT04844190 | Northwestern University | N/A |
| Completed | Atmo SmartPill Comparison in Gastroparetic and Slow Transit Constipation Patients NCT04977063 | Atmo Biosciences Pty Ltd | N/A |
| Completed | ConMed Beamer Study NCT04752670 | Baylor College of Medicine | — |
| Completed | ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve -B NCT06827548 | Indiana University | N/A |
| Completed | Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastropare NCT04857281 | Johns Hopkins University | N/A |
| Unknown | Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study NCT05041608 | Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University | — |
| Completed | GEBT Lot-to-Lot and Biological Variability NCT04772261 | Cairn Diagnostics | N/A |
| Completed | GEBT Telehealth Administration Usability Study NCT04684992 | Cairn Diagnostics | N/A |
| Terminated | 13C-Spirulina Nitrogen Content GEBT Study NCT04635306 | Cairn Diagnostics | N/A |
| Enrolling By Invitation | Indiana University Gastric Electrical Stimulation Registry NCT05047289 | Indiana University | — |
| Completed | ABCA2 GIRMS Analytical Validation Clinical Performance Study NCT04607304 | Cairn Diagnostics | N/A |
| Terminated | Transcutaneous Electroacupuncture for Gastrointestinal Motility Disorders NCT04349891 | Johns Hopkins University | N/A |
| Active Not Recruiting | ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve NCT06491758 | Indiana University | N/A |
| Unknown | Safety and Efficacy of GPOEM in the Treatment of Gastroparesis NCT04349670 | IRCCS San Raffaele | — |
| Unknown | Use of Intrapyloric Botulinum Injections in Children NCT04250844 | Boston Children's Hospital | — |
| Recruiting | IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy NCT04208828 | University of Louisville | — |
| Completed | Controlled Trial of Gastric Electrical Stimulation in Children NCT07474415 | Nationwide Children's Hospital | N/A |
| Completed | Pioglitazone for Idiopathic Gastroparesis NCT04300127 | Johns Hopkins University | EARLY_Phase 1 |
| Terminated | A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis NCT04026997 | CinDome Pharma, Inc. | Phase 2 |
| Completed | Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia NCT03941288 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Vagus Nerve Response in Gastroparesis Patients NCT04207996 | Indiana University | — |
| Completed | Buspirone for Early Satiety and Symptoms of Gastroparesis NCT03587142 | Johns Hopkins Bloomberg School of Public Health | Phase 2 |
| Completed | Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis NCT04028492 | Vanda Pharmaceuticals | Phase 3 |
| Active Not Recruiting | Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis NCT04282317 | Indiana University School of Medicine | N/A |
| Terminated | Study to Intervene With Nutrition for Gastroparesis NCT03987672 | Stanford University | N/A |
| Recruiting | Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis NCT04287647 | Northwestern University | N/A |
| Withdrawn | Nutritional Drink in Gastroparesis NCT03500354 | Johns Hopkins University | N/A |
| Completed | A Study of CNSA-001 in Women With Diabetic Gastroparesis NCT03712124 | PTC Therapeutics | Phase 2 |
| Completed | Gastroparesis Registry 3 NCT03680859 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | Pediatric Gastroparesis Registry NCT03680820 | Johns Hopkins Bloomberg School of Public Health | — |
| Terminated | GI-Challenge Study for Gastroparesis Patients and Healthy Controls NCT03896126 | Stanford University | — |
| Withdrawn | Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis NCT04501211 | Indiana University | Phase 2 |
| Terminated | Diabetic Gastroparesis Study 05 NCT03786380 | Allergan | Phase 3 |
| Recruiting | Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Pa NCT03531450 | Massachusetts General Hospital | N/A |
| Recruiting | Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis NCT03603730 | Massachusetts General Hospital | N/A |
| Unknown | Ultrasound Assessment of Gastric Contents in Fasted Surgical Patients With Previous Subtotal Gastrectomy NCT03802006 | Seoul National University Hospital | — |
| Completed | Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After G-POEM NCT03679104 | Institute for Clinical and Experimental Medicine | N/A |
| Recruiting | Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis NCT04434781 | Indiana University | — |
| Active Not Recruiting | Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy NCT03626350 | University of Colorado, Denver | — |
| Unknown | Role of Gastric Ultrasound in Preoperative Assessment of Gastric Volume in Diabetic Patients. NCT03438305 | Cairo University | — |
| Terminated | Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 NCT03426345 | Allergan | Phase 3 |
| Terminated | A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 NCT03383146 | Allergan | Phase 3 |
| Terminated | A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 NCT03420781 | Allergan | Phase 3 |
| Unknown | The Effect of Gluten-free Diet in Type 1 Diabetics With Dyspepsia Symptoms NCT03089632 | McMaster University | N/A |
| Completed | Endoscopic Pyloromyotomy for Refractory Gastroparesis NCT03356067 | Institute for Clinical and Experimental Medicine | N/A |
| Completed | Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy NCT03259841 | SMG-SNU Boramae Medical Center | — |
| Unknown | GPOEM Versus SHAM as a Treatement of Gastroparesis NCT04552184 | Erasme University Hospital | N/A |
| Terminated | A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 NCT03285308 | Allergan | Phase 3 |
| Completed | Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness NCT03011151 | Boston Children's Hospital | — |
| Terminated | Vagal Nerve Stimulation for Gastroparesis NCT03120325 | Stanford University | N/A |
| Completed | Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma NCT03294616 | Johns Hopkins University | N/A |
| Completed | Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis NCT03123809 | Texas Tech University Health Sciences Center, El Paso | N/A |
| Completed | Long-term Results of Per-oral Pyloromyotomy for Refractory Gastroparesis NCT04024709 | University Hospital, Limoges | — |
| Withdrawn | Naloxegol for Opioid-Related Gastroparesis NCT03036891 | Temple University | Phase 2 |
| Unknown | Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective NCT02927886 | Assistance Publique Hopitaux De Marseille | Phase 3 |
| Completed | Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis NCT02970968 | Vanda Pharmaceuticals | Phase 2 |
| Completed | RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease NCT02838797 | Virginia Commonwealth University | Phase 1 |
| Completed | Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study. NCT02779920 | University Hospital, Limoges | N/A |
| Completed | Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers NCT02736799 | Vibrant Ltd. | N/A |
| Completed | Determination of the Characteristics of Isometric Gastric Motility Measurement in Healthy Volunteers NCT03441230 | Prof Dr Jan Tack | N/A |
| Unknown | Acupuncture for Diabetic Gastroparalysis: a Randomized Controlled Trial NCT02594397 | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine | N/A |
| Enrolling By Invitation | Medtronic Enterra II Neurostimulator NCT06215547 | Methodist Health System | N/A |
| Completed | Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes NCT02324010 | Royal Adelaide Hospital | Phase 2 |
| Unknown | Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlip NCT02446119 | Temple University | — |
| Completed | Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe NCT02357420 | Allergan | Phase 2 |
| Completed | The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study NCT02267525 | Theravance Biopharma | Phase 2 |
| Recruiting | Indiana University Gastrointestinal Motility Diagnosis Registry NCT04506593 | Indiana University | — |
| Withdrawn | Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis NCT02420925 | Linda Nguyen | N/A |
| Completed | A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With G NCT02210000 | GlaxoSmithKline | Phase 2 |
| Completed | Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects NCT02232308 | Adil Bharucha | Phase 1 |
| Completed | Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis NCT02187094 | Targacept Inc. | Phase 1 / Phase 2 |
| Terminated | Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study NCT01934192 | GlaxoSmithKline | Phase 2 |
| Completed | Autonomic and Enteric Profiling NCT03178370 | University of Louisville | — |
| Completed | Prucalopride Versus Placebo in Gastroparesis NCT02031081 | University of Calgary | Phase 2 / Phase 3 |
| Terminated | Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastr NCT02022826 | Medtronic - MITG | N/A |
| Recruiting | GI Neuromuscular Pathology Prospective Registry NCT02165059 | Indiana University | — |
| Unknown | Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People NCT02308254 | Royal Adelaide Hospital | Phase 1 / Phase 2 |
| Recruiting | Compassionate Use of Domperidone for Refractory Gastroparesis NCT04699591 | Jose Cocjin | N/A |
| Completed | Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Tr NCT01149369 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Terminated | Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis NCT02164591 | Indiana University | — |
| Recruiting | Gastroparesis Outcome Longitudinal Database Enrolled Numerically NCT03876288 | University of Louisville | — |
| Unknown | IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the St NCT01858220 | Sheba Medical Center | — |
| Completed | Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis NCT01718938 | Theravance Biopharma | Phase 2 |
| Terminated | Haloperidol vs Conventional Therapy for Gastroparesis NCT02057549 | The University of Texas Health Science Center, Houston | Phase 4 |
| Active Not Recruiting | Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve NCT02159586 | Indiana University | — |
| Completed | Sancuso® for Gastroparesis: An Open Label Study. NCT01989221 | Temple University | Phase 3 |
| Recruiting | Domperidone in Treating Patients With Gastrointestinal Disorders NCT01696734 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Endoscopic Full Thickness Biopsy, Gastric Wall. NCT01650714 | Mayo Clinic | N/A |
| Completed | Gastroparesis Registry 2 NCT01696747 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With P NCT01602549 | GlaxoSmithKline | Phase 2 |
| Completed | Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis NCT01571297 | Motus Therapeutics, Inc. | Phase 2 |
| Completed | Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis NCT01519180 | University Hospital, Rouen | — |
| Terminated | Prucalopride Versus Placebo in Gastroparesis NCT02510976 | Universitaire Ziekenhuizen KU Leuven | Phase 4 |
| Completed | Acupuncture Treatment for Gastroparesis: a Pilot Study NCT01643577 | Johns Hopkins University | Phase 1 / Phase 2 |
| Completed | Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gas NCT01452815 | Tranzyme, Inc. | Phase 2 |
| Completed | Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis NCT01394055 | Motus Therapeutics, Inc. | Phase 1 |
| Completed | Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastro NCT01262898 | GlaxoSmithKline | Phase 2 |
| Withdrawn | Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis NCT01326117 | Mark Feinglos | Phase 4 |
| Completed | Gastric Emptying in Elderly With Hip Fracture NCT02753010 | Uppsala University | — |
| Completed | Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms NCT01316484 | Tranzyme, Inc. | — |
| Completed | FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Cauc NCT01294566 | GlaxoSmithKline | Phase 1 |
| Completed | A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simul NCT01267071 | GlaxoSmithKline | Phase 1 |
| Terminated | Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification NCT01173484 | University of Louisville | — |
| Completed | Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis. NCT01135186 | Stanford University | N/A |
| Completed | A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) NCT01206582 | Mayo Clinic | Phase 2 |
| Terminated | Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients NCT01117376 | Shiraz University of Medical Sciences | Phase 2 |
| Withdrawn | The Use of Domperidone for Gastroparesis NCT01378884 | Allegiance Health | Phase 3 |
| Completed | Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers NCT01074710 | Otsuka Pharmaceutical Co., Ltd. | Phase 1 |
| Terminated | Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers NCT01329211 | University of Florida | — |
| Completed | Temporary Gastric Electrical Stimulation for Gastroparesis NCT01054794 | University of Calgary | N/A |
| Completed | Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance NCT01039805 | GlaxoSmithKline | Phase 2 |
| Completed | GSK962040 Drug-drug Interaction Study With Ketoconazole NCT01039974 | GlaxoSmithKline | Phase 1 |
| Completed | Medico-economic Evaluation of ENTERRA Therapy NCT00903799 | University Hospital, Rouen | N/A |
| Completed | The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastropa NCT00861809 | GlaxoSmithKline | Phase 2 |
| Completed | Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes NCT00889486 | Tranzyme, Inc. | Phase 2 |
| Completed | Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis NCT00845858 | Evoke Pharma | Phase 2 |
| Terminated | Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis NCT01323582 | University of Florida | Phase 2 |
| Unknown | Domperidone for Refractory Gastrointestinal Disorders NCT00777439 | Arnold, George, M.D. | N/A |
| Terminated | Domperidone in Refractory Gastroparesis NCT00760461 | Yale University | Phase 2 |
| Completed | Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to NCT00733551 | GlaxoSmithKline | Phase 1 |
| Terminated | Domperidone for Relief of Gastrointestinal Disorders NCT00761254 | Carle Physician Group | N/A |
| Completed | Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastrop NCT00612014 | Tranzyme, Inc. | Phase 2 |
| Completed | A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 NCT00562848 | GlaxoSmithKline | Phase 1 |
| Completed | A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old NCT00682877 | The SmartPill Corporation | — |
| Completed | Effects of Sitagliptin on Gastric Emptying in Healthy Subjects NCT00501657 | Royal Adelaide Hospital | Phase 1 |
| Completed | Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis NCT00492622 | University of Louisville | Phase 4 |
| Withdrawn | Gastric Pacemaker Implantation for Gastroparesis NCT00568373 | Indiana University | N/A |
| Terminated | Domperidone for Gastroparesis in Solid Organ Transplantation NCT00552422 | David J. Lederer, M.D. | N/A |
| Terminated | Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis NCT00390975 | Novartis | Phase 4 |
| Completed | Gastroparesis Registry NCT00398801 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis NCT00639808 | Tranzyme, Inc. | Phase 1 |
| Completed | Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis NCT00432835 | University of Mississippi Medical Center | Phase 3 |
| Completed | Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia NCT00370084 | Forest Laboratories | Phase 1 / Phase 2 |
| Completed | A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time NCT00128284 | The SmartPill Corporation | — |
| Terminated | Enterra Therapy Gastric Stimulation System NCT00556166 | Columbia University | Phase 4 |
| Terminated | An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients Wit NCT01286090 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 4 |
| Completed | Placebo Controlled Trial of Botulinum Toxin for Gastroparesis NCT00372970 | Temple University | N/A |
| Terminated | An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatm NCT01281540 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 4 |
| Completed | Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach E NCT00050609 | Eli Lilly and Company | Phase 2 |
| Terminated | Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis) NCT00157755 | MedtronicNeuro | N/A |
| Completed | Limited Access Protocol for the Use of Oral Cisapride NCT02524496 | Yale University | — |
| Unknown | Effect of Electroacupuncture in Diabetic Patients With Gastroparesis NCT00227383 | China Medical University Hospital | Phase 3 |
| No Longer Available | Domperidone Expanded Access Treatment Program NCT04996134 | Wake Forest University Health Sciences | — |
| No Longer Available | Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders NCT02567175 | Prasanna K Kapavarapu | — |
| Completed | Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis NCT00050882 | Chugai Pharma USA | Phase 2 |
| No Longer Available | Domperidone for Chronic Nausea and Vomiting NCT02757534 | Yehudith Assouline-Dayan | — |
| No Longer Available | The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms NCT03810287 | Yale University | — |
| No Longer Available | Treatment Use of Domperidone for Gastroparesis NCT02227927 | Scott Gabbard, MD | — |
| No Longer Available | Use of Domperidone for Treatment of Upper Gastrointestinal Disorders NCT03128398 | Palo Alto Medical Foundation | — |
| Available | Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis NCT04474990 | Vanda Pharmaceuticals | — |